期刊文献+

声触诊组织量化技术评估慢性肝纤维化的应用研究 被引量:1

Application of virtual touch tissue quantification technique in the assessment of liver fibrosis
下载PDF
导出
摘要 目的探讨采用声触诊组织量化(VTQ)技术评估肝实质纤维化的应用价值。方法应用VTQ技术对36例慢性乙型肝炎患者和55例健康志愿者的肝实质进行检测,用9L4线阵超声探头测定肝实质的剪切波速度(SWV)。结果健康对照组和慢性乙型肝炎组缺失值出现率分别为26.55%和51.11%,差异有统计学意义(P<0.01);健康对照组和慢性乙型肝炎组SWV测值分别为(1.35±0.39)m/s和(2.27±0.76)m/s,健康对照组小于慢性乙型肝炎组(P<0.05)。通过ROC曲线确定变量的临界值为1.79 m/s,曲线下面积为0.94(P<0.05),对应的敏感度、特异度、阳性似然比、阴性似然比和Youden指数分别为86.89%、91.11%、9.77、0.14和0.78。结论 VTQ可快速无创测量肝实质剪切波速度,可客观反映肝组织的弹性模量。 Objective To explore the values of virtual touch tissue quantification (VTQ)in the assessment of liver fibrosis.Methods 36 patients with chronic hepatitis B (CHB group)and 55 healthy volunteers (control group)were recruited.The shear wave velocity (SWV)of the right hepatic lobe was measured by linear (9L4)array transducer.Results There were significant difference in the occurrence rate of missing data using the 9L4 transducer between control group and CHB groups,which was 26.55%and 51.11%,respectively (P<0.01).The SWV of con-trol group and CHBs were(1.35 ±0.39)m/s and (2.27 ±0.76)m/s (P<0.05).The cut-off level was 1.79 m/s and area under the receiver-operating characteristic curve (AUROC)was 0.95 according to the ROC curves,and the corresponding sensitivity,specificity,positive likelihood ratio,negative likelihood ratio,and Youden''s index were 86. 89%,91.11%,9.77,0.14,and 0.78,respectively.Conclusion VTQ is a reliable,noninvasive and rapid method for estimating the value of SWV,which may reflect the elastic modulus of liver tissues objectively.
作者 郭雯 孙培育
出处 《中国临床保健杂志》 CAS 2013年第6期607-608,680,共3页 Chinese Journal of Clinical Healthcare
关键词 肝硬化 肝炎 乙型 慢性 超声检查 弹性成像技术 Liver cirrhosis Hepatitis B,chronic Ultrasonography Elasticity imaging techniques
  • 相关文献

参考文献2

二级参考文献49

  • 1罗建文,白净.超声弹性成像的研究进展[J].中国医疗器械信息,2005,11(5):23-31. 被引量:150
  • 2Bravo AA, Sheth SG, Chopra S. Liver biopsy. NEngl J Med 2001; 344: 495-500.
  • 3Abdi W, Millan JC, Mezey E. Sampling variability on percu- taneous liver biopsy. Arch Intern Med 1979; 139: 667-669.
  • 4Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
  • 5Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481.
  • 6Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ. Sampling variability and its influ- ence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525.
  • 7Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
  • 8Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-Lyon I, Williams R. Noninvasive markers of fibrosis and inflamma- tion in clinical practice: prospective comparison with liver biopsy. Eur J GastroenterolHepatol 2010; 22: 474-480.
  • 9Angulo P. Noninvasive assessment of fibrosis and steatosis in NASH and ASH. Gastroenterol Clin Biol 2009; 33: 940-948.
  • 10Attallah AM, Toson EA, Shiha GE, Omran MM, Abdel-Aziz MM, El-Dosoky I. Evaluation of serum procollagenamino- terminalpropeptide III, laminin, and hydroxyproline as pre- dictors of severe fibrosis in patients with chronic hepatitis C. J Immunoassay Immunochem 2007; 28: 199-211.

共引文献59

同被引文献18

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部